Prof. Andreas Skolarikos (University of Athens, Greece) provided practical tips and tricks to reduce radiation exposure in both the patient and attending endourologist [1]. Patients with nephrolithiasis are at risk for significant radiation exposure from diagnostic imaging. In addition, fluoroscopy used during surgical treatment of nephrolithiasis also contributes to radiation exposure for patient as well as endourologist. Patients receive even more radiation from surgery than from a non-contrast computed tomography (CT) of the abdomen and pelvis. However, a recent survey on the knowledge on radiation exposure and compliance to wearing protective equipment among endourologists indicated substantial lack of knowledge and awareness regarding their occupational radiation [2]. Nonetheless, compared with interventional radiologists, cardiologists, and vascular surgeons, urologists are exposed by far to the highest levels of radiation, with exposure levels over 18-fold compared to cardiologists [3].
Ionising radiation is an essential part of any urological practice. In general, Prof. Skolarikos said, radiation exposure can be minimised in 2 ways: either by using use no radiation at all or by following the ALARA (as low as reasonably achievable) principles. In the aforementioned survey, only 42% of endourologists were familiar with the ALARA principles [2]. An example of one easy adjustment is the use of ultrasound in percutaneous nephrolithotomy (PCNL) together with fluoroscopy, which reduced the fluoroscopic time and therefore reduced radiation exposure [4].
In urological practice you want to protect the patient, yourself, and the operating personnel. The primary beam interaction with the patient produces scatter radiation that comes to the personnel in the operating theatre. Anything done to reduce patient exposure will likewise reduce the personnel exposure. Some of the tips and tricks shared by Prof. Skolarikos included:
- Be aware of your patient’s previous exposure. The longitudinal exposure of stone patients to ionising radiation from CT imaging and fluoroscopy during surgery is poorly defined.
- Be aware that ionising radiation from the management of nephrolithiasis carries a small but significant increased risk of a secondary malignancy.
- Reduce the fluoroscopy time by adapting simple techniques, like not magnifying the image and keeping the image intensifier close to the patient’s body (see Figure). It is essential to be vigilant of the image intensifier usage, thereby reducing radiation exposure to the surgeon and the patient [5].
- Keep the C-arm low to the patient, which will improve image quality as well as reducing patient and operator exposure.
- Reduce patient dose by using pulsed instead of continuous fluoroscopy together with collimation, which reduces the scattered radiation produced by 5-fold. [6]. Another trick is to minimise field overlap by not turning the C-arm to extreme angles [7].
- Avoid digital acquisitions, which leads to 5-10 times higher exposure to fluoroscopy, and rely on the last-image-hold feature. Audible indicators of fluoroscopic time and measures of cumulative dose may further protect against exposure.
- Urologists should always be protected by structural and/or mobile shielding, provided the shielding covers the patient where scattered radiation would originate, and personal shielding (i.e. gown, thyroid collar, optional eye protection, but not radiation protective gloves, as these can increase the radiation dose to the hands).
- Always use the X-ray source underneath the patient (i.e. under-couch), and as close to the patient as possible, as 1 study demonstrated operator radiation exposure to be significantly lower for under-couch versus over-couch setups (P<0.001) [8].
- Patient positioning remains a debate, although a recent randomised controlled study showed that ultrasound-guided PCNL either in prone or supine position is as effective, feasible, and safe as conventional nephrolithotomy with zero radiation exposure [9,10].
Figure kindly provided by Prof. Skolarikos.
Prof. Skolarikos concluded that urologists and surgical staff require additional training in radiation and radiation exposure. He urged that radiometers should be evaluated monthly. The rules for staff protection have been well described [11], but it is well known that the exposure of staff is considerably lower than the exposure to the surgeon.
- Skolarikos A, et al. EAU20 Virtual Congress, 17-26 July 2020, State-of-the-art lecture.
- Tzelves L, et al. World J Urol. 2020;38(3):761-768.
- Vano E, et al. J Radiol Prot. 2016;36(1):37-48.
- Lipkin ME, Preminger GM. Curr Opin Urol. 2012;22(2):139-143.
- Sourial MW, et al. J Endourol. 2019;33(5):369-374.
- Durutovic O, et al. 2016;44(6):565-570.
- Balter S. Radiology. 2019;290(3):750-751.
- Harris AM. Urology. 2018;114:45-48.
- Galonnier F, et al. J Endourol. 2016;30(6):638-643.
- El-Shaer W, et al. 2019;128:31-37.
- Jindal T. Urol Nurs. 2013;33(3):136-147.
Posted on
Previous Article
« Letter from the Editor Next Article
Pressure and temperature: do high-power lasers pose a threat? »
« Letter from the Editor Next Article
Pressure and temperature: do high-power lasers pose a threat? »
Table of Contents: EAU 2020
Featured articles
Surgical Techniques and Safety
The new adjustable artificial sphincter victo: Surgical technique and results after a follow-up of more than one year
New urosepsis data from the SERPENS study
Stones
Intra-operative cone-beam computed tomography for detecting residual stones in percutaneous nephrolithotomy
Pressure and temperature: do high-power lasers pose a threat?
Radiation stewardship for patient and endourologist
New lithotripter data: improved stone clearance
Renal Cancer
Beyond the limits of ultrasound: Three dimensional augmented reality robot assisted partial nephrectomy (3D AR-RAPN) for complex renal masses
Imaging guided surgery with augmented reality for robotic partial nephrectomy
KEYNOTE-426: no QoL differences pembrolizumab + axitinib versus sunitinib
Debate: upfront cytoreductive nephrectomy or not?
Robotic-assisted partial nephrectomy: lower morbidity
Bladder Cancer
Reduced BCG frequency, faster NMIBC recurrence
Nadofaragene firadenovec effective in BCG-unresponsive papillary NMIBC
Understanding MIBC biology for novel treatment options
Prostate Cancer & Imaging
Transperineal laser ablation of prostate
Prostatectomy: R-LRPE better than LRPE for continence
PSMA PET-CT staging is 27% more accurate
Docetaxel + hormonal therapy: improved prostate cancer PFS
ARAMIS subgroup analysis: darolutamide benefits across PSADT groups
Large patient-driven survey reveals QoL issues after prostate cancer treatment
Targeting steroid sulphatase in resistant prostate cancer cells
Good tolerance of post-RP radiotherapy ± short-term ADT
BPH & LUTS
Minimizing post-operative stress urinary incontinence after HoLEP: Our preliminary experience and short-term results of ‘’En Bloc’’ technique with early apical release
LUTS 2-year outcomes: aquablation versus TURP
HoLEP versus PVP in prospective randomised trial
Testis Cancer & Andrology
Peyronie’s disease: surgical options
Infertility and testis cancer risk: causal or association?
32% more men complain of reduced sex drive in 2019 versus 2009
Related Articles
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com